Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1955 1
1958 3
1959 1
1962 1
1963 3
1964 1
1966 2
1967 1
1968 1
1969 1
1970 2
1971 1
1972 1
1973 4
1974 3
1975 3
1976 1
1977 5
1978 8
1979 3
1980 7
1981 3
1982 8
1983 5
1984 4
1985 6
1986 4
1987 4
1988 8
1989 9
1990 3
1991 8
1992 3
1993 6
1994 6
1995 5
1996 8
1997 2
1998 8
1999 8
2000 14
2001 6
2002 9
2003 9
2004 6
2005 12
2006 5
2007 10
2008 7
2009 12
2010 10
2011 9
2012 16
2013 13
2014 15
2015 19
2016 15
2017 12
2018 11
2019 13
2020 9
2021 9
2022 7
2023 4
2024 4
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

403 results

Results by year

Filters applied: . Clear all
Page 1
Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement.
Kapadia SR, Makkar R, Leon M, Abdel-Wahab M, Waggoner T, Massberg S, Rottbauer W, Horr S, Sondergaard L, Karha J, Gooley R, Satler L, Stoler RC, Messé SR, Baron SJ, Seeger J, Kodali S, Krishnaswamy A, Thourani VH, Harrington K, Pocock S, Modolo R, Allocco DJ, Meredith IT, Linke A; PROTECTED TAVR Investigators. Kapadia SR, et al. N Engl J Med. 2022 Oct 6;387(14):1253-1263. doi: 10.1056/NEJMoa2204961. Epub 2022 Sep 17. N Engl J Med. 2022. PMID: 36121045 Clinical Trial.
Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients.
Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, Adams DH, Deeb GM, Maini B, Gada H, Chetcuti S, Gleason T, Heiser J, Lange R, Merhi W, Oh JK, Olsen PS, Piazza N, Williams M, Windecker S, Yakubov SJ, Grube E, Makkar R, Lee JS, Conte J, Vang E, Nguyen H, Chang Y, Mugglin AS, Serruys PW, Kappetein AP; SURTAVI Investigators. Reardon MJ, et al. N Engl J Med. 2017 Apr 6;376(14):1321-1331. doi: 10.1056/NEJMoa1700456. Epub 2017 Mar 17. N Engl J Med. 2017. PMID: 28304219 Free article. Clinical Trial.
Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial.
Van Mieghem NM, Deeb GM, Søndergaard L, Grube E, Windecker S, Gada H, Mumtaz M, Olsen PS, Heiser JC, Merhi W, Kleiman NS, Chetcuti SJ, Gleason TG, Lee JS, Cheng W, Makkar RR, Crestanello J, George B, George I, Kodali S, Yakubov SJ, Serruys PW, Lange R, Piazza N, Williams MR, Oh JK, Adams DH, Li S, Reardon MJ; SURTAVI Trial Investigators. Van Mieghem NM, et al. JAMA Cardiol. 2022 Oct 1;7(10):1000-1008. doi: 10.1001/jamacardio.2022.2695. JAMA Cardiol. 2022. PMID: 36001335 Free PMC article. Clinical Trial.
KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in NUP98-Rearranged Acute Myeloid Leukemia.
Michmerhuizen NL, Heikamp EB, Iacobucci I, Umeda M, Arthur B, Mishra V, Park CS, Di Giacomo D, Hiltenbrand R, Gao Q, Radko-Juettner S, Lott J, Martucci C, Subramanyam V, Hatton C, Wenge DV, Baviskar P, Portola P, Claquin A, Chandra B, Baggett DW, Khalighifar A, Huang H, Zhou P, Long L, Shi H, Sun Y, Papachristou EK, Sekhar Reddy Chilamakuri C, de Luna Vitorino FN, Gongora JM, Wu H, Pounds SB, Janke LJ, Kentsis A, D'Santos CS, Garcia BA, Kriwacki RW, Chi H, Klco JM, Armstrong SA, Mullighan CG. Michmerhuizen NL, et al. Among authors: lott j. Cancer Discov. 2025 Oct 6;15(10):2096-2116. doi: 10.1158/2159-8290.CD-24-1772. Cancer Discov. 2025. PMID: 40536430 Free PMC article.
Fate of micronuclei and micronucleated cells.
Hintzsche H, Hemmann U, Poth A, Utesch D, Lott J, Stopper H; Working Group “In vitro micronucleus test”, Gesellschaft für Umwelt-Mutationsforschung (GUM, German-speaking section of the European Environmental Mutagenesis and Genomics Society EEMGS). Hintzsche H, et al. Among authors: lott j. Mutat Res Rev Mutat Res. 2017 Jan-Mar;771:85-98. doi: 10.1016/j.mrrev.2017.02.002. Epub 2017 Feb 13. Mutat Res Rev Mutat Res. 2017. PMID: 28342454 Review.
Venetoclax plus gilteritinib is effective in preclinical models of FLT3-mutant BCL11B-a lineage-ambiguous leukemia.
Montefiori LE, Iacobucci I, Gao Q, Moore J, Wright WC, Wei H, Baviskar P, Sona S, Jin H, Budhraja A, Lott J, Tatarata QZ, Cheng Z, Khan TM, Backhaus EA, Johnson MD, Mehr CM, Freeman BB 3rd, Janke LJ, Haferlach T, Geeleher P, Mead PE, Konopleva MY, Opferman JT, Mullighan CG. Montefiori LE, et al. Among authors: lott j. Blood. 2025 Aug 14:blood.2025028985. doi: 10.1182/blood.2025028985. Online ahead of print. Blood. 2025. PMID: 40811853 Free PMC article.
A note on normality.
Lott JP. Lott JP. J Am Acad Dermatol. 2015 Jun;72(6):e169-70. doi: 10.1016/j.jaad.2015.01.051. J Am Acad Dermatol. 2015. PMID: 25981027 No abstract available.
Solid-organ transplantation.
Lott JA. Lott JA. Anal Chem. 1995 Jun 15;67(12):417R-424R. doi: 10.1021/ac00108a024. Anal Chem. 1995. PMID: 8686863 Review. No abstract available.
Membrane trafficking pathways regulating the epithelial Na+ channel.
Ware AW, Rasulov SR, Cheung TT, Lott JS, McDonald FJ. Ware AW, et al. Among authors: lott js. Am J Physiol Renal Physiol. 2020 Jan 1;318(1):F1-F13. doi: 10.1152/ajprenal.00277.2019. Epub 2019 Oct 28. Am J Physiol Renal Physiol. 2020. PMID: 31657249 Free article. Review.
RCTs.
Lott JW. Lott JW. Neonatal Netw. 1989 Feb;7(4):53-4. Neonatal Netw. 1989. PMID: 2915639 No abstract available.
403 results